Journal of Andrology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by WICKINGS, E. J.
Right arrow Articles by NIESCHLAG, E.
Right arrow Search for Related Content
PubMed
Right arrow Articles by WICKINGS, E. J.
Right arrow Articles by NIESCHLAG, E.
Journal of Andrology, Vol 2, Issue 2 72-79, Copyright © 1981 by The American Society of Andrology

Effects of Chronic, High-dose LHRH-Agonist Treatment on Pituitary and Testicular Functions in Rhesus Monkeys

E. JEAN WICKINGS 1, PERVEEN ZAIDI 1, AND EBERHARD NIESCHLAG 1

1 Abteilung Experimentelle Endokrinologie, Universitäts-Frauenklinik, Münster, Federal Republic of Germany

The effects of chronic, high-dose treatment with an LHRH-agonist (D-Ser-(TBu)6-LHRH-ethylamide) on pituitary and testicular functions were investigated in four adult rhesus monkeys in-season. Doses of 4 µg of agonist per day for eight weeks followed by 20 µg/day for four weeks caused a significant decrease in testicular volume and a transient suppression of sperm counts, although counts at the end of treatment were not different from control values. Basal levels of LH were not altered by chronic treatment. Responses to acute stimulation with high and low doses of LHRH or the agonist were measured in terms of the LH increase over basal values and the cumulative response. The results indicate that the pituitary capacity was not affected, but that the sensitivity to low doses was decreased after 12 weeks. Basal testosterone concentrations were decreased during the early and later phases of treatment. The testosterone increase in response to acute stimulation with LHRH or its agonist was not suppressed by chronic treatment, although the cumulative response to low doses of both substances was less after 12 weeks of treatment with high doses of the agonist.

Submitted on September 8, 1980
Revised on December 1, 1980
Accepted on December 1, 1980







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1981 by The American Society of Andrology.